Novo Nordisk 4466 – Insulin Glargine (Lantus) Study

Enroll Now

Type of Study:

Type 2 diabetes patients who are between 18 to 75 years who are already taking insulin.

Title of Study:

This study will assess a once a week insulin to a daily insulin in patients with Type 2 diabetes.

Short Title:

NN 4466

Study Length: 5 months

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov